GUO Xuesong, MIAO Wenjing, FENG Xiujuan, WANG Dahai, WANG Chunyan, CHEN Liye. The expression and clinical significance of lymphocyte subsets and immunoglobulins in children with autism spectrum disorder[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 111-114, 124. DOI: 10.7619/jcmp.20233562
Citation: GUO Xuesong, MIAO Wenjing, FENG Xiujuan, WANG Dahai, WANG Chunyan, CHEN Liye. The expression and clinical significance of lymphocyte subsets and immunoglobulins in children with autism spectrum disorder[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 111-114, 124. DOI: 10.7619/jcmp.20233562

The expression and clinical significance of lymphocyte subsets and immunoglobulins in children with autism spectrum disorder

More Information
  • Received Date: November 07, 2023
  • Revised Date: January 09, 2024
  • Available Online: March 05, 2024
  • Objective 

    To investigate the expression levels and clinical significance of absolute counts of lymphocyte subsets and immunoglobulins (Ig) in peripheral blood of children with autism spectrum disorder (ASD).

    Methods 

    Seventy-five children with ASD were selected as study group, and another 75 healthy children who underwent physical examination were selected as control group. Flow cytometry was used to detect the absolute counts of lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, CD56+CD16+) and IgA, IgG, IgM levels in peripheral blood of both groups of children. Pearson correlation analysis was used to explore the correlation between each detection index and the total score of the Childhood Autism Rating Scale (CARS).

    Results 

    The number of absolute counts of CD3+ and CD4+ in the study group were (62.49±8.71) and (34.87±7.86) in one μL, respectively, which were separately lower than (67.73±5.11) and (39.56±4.60)]in one μL in the control group (P < 0.05). There were no significant differences in the absolute counts of CD8+, CD19+, CD56+CD16+ between the two groups (P>0.05). The levels of IgA, IgG, IgM in the study group were (0.79±0.33), (8.39±2.03), (0.95±0.27), respectively, which were lower than (0.94±0.29), (9.28±1.37), (1.16±0.39) in the control group (P < 0.05). Pearson correlation analysis showed that IgA level was significantly negatively correlated with CARS total score (r= -0.317, P=0.034), while the absolute counts of CD3+, CD4+, CD8+, CD19+, CD56+CD16+ and IgG, IgM levels had no correlation with CARS total score (P>0.05).

    Conclusion 

    Abnormal expression levels of lymphocyte subsets and Ig-mediated immune dysfunction are closely related to the occurrence of ASD in children. CD3+, CD4+, IgA, IgG, and IgM can be used as potential biological indicators for screening the immunological etiology of ASD in children, and IgA can be used as an indicator for evaluating the efficacy of ASD children with immunological etiology.

  • [1]
    占红, 白淑霞, 王金堂. 屏幕暴露与儿童孤独症谱系障碍的相关性研究[J]. 实用临床医药杂志, 2021, 25(22): 46-49, 54. doi: 10.7619/jcmp.20212094
    [2]
    ROBINSON-AGRAMONTE M L A, NORIS GARCÍA E, FRAGA GUERRA J, et al. Immune dysregulation in autism spectrum disorder: what do we know about it[J]. Int J Mol Sci, 2022, 23(6): 3033. doi: 10.3390/ijms23063033
    [3]
    PANGRAZZI L, BALASCO L, BOZZI Y. Oxidative stress and immune system dysfunction in autism spectrum disorders[J]. Int J Mol Sci, 2020, 21(9): 3293. doi: 10.3390/ijms21093293
    [4]
    BAXTER A J, BRUGHA T S, ERSKINE H E, et al. The epidemiology and global burden of autism spectrum disorders[J]. Psychol Med, 2015, 45(3): 601-613. doi: 10.1017/S003329171400172X
    [5]
    MAENNER M J, WARREN Z, WILLIAMS A R, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2020[J]. MMWR Surveill Summ, 2023, 72: 1-14.
    [6]
    ZHOU H, XU X, YAN W L, et al. Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years[J]. Neurosci Bull, 2020, 36(9): 961-971. doi: 10.1007/s12264-020-00530-6
    [7]
    谢姝, 刘瑜, 李德欣, 等. 内源性大麻素系统对孤独症谱系障碍异常神经炎症反应调控作用的研究进展[J]. 中国儿童保健杂志, 2022, 30(4): 392-395. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202204010.htm
    [8]
    卢彦宇, 韩颖. 孤独症谱系障碍的免疫相关机制与治疗研究进展[J]. 中华儿科杂志, 2022, 60(5): 482-486. https://www.cnki.com.cn/Article/CJFDTOTAL-YXJZ202304005.htm
    [9]
    MOLLOY C A, MORROW A L, MEINZEN-DERR J, et al. Elevated cytokine levels in children with autism spectrum disorder[J]. J Neuroimmunol, 2006, 172(1/2): 198-205.
    [10]
    GUPTA S. Immunological treatments for autism[J]. J Autism Dev Disord, 2000, 30(5): 475-479. doi: 10.1023/A:1005568027292
    [11]
    ASHWOOD P, KRAKOWIAK P, HERTZ-PICCIOTTO I, et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome[J]. Brain Behav Immun, 2011, 25(1): 40-45. doi: 10.1016/j.bbi.2010.08.003
    [12]
    GŁADYSZ D, KRZYWDZINSKA A, HOZYASZ K K. Immune abnormalities in autism spectrum disorder-could they hold promise for causative treatment[J]. Mol Neurobiol, 2018, 55(8): 6387-6435. doi: 10.1007/s12035-017-0822-x
    [13]
    WARREN R P, ODELL J D, WARREN W L, et al. Brief report: immunoglobulin A deficiency in a subset of autistic subjects[J]. J Autism Dev Disord, 1997, 27(2): 187-192. doi: 10.1023/A:1025895925178
    [14]
    HEUER L, ASHWOOD P, SCHAUER J, et al. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms[J]. Autism Res, 2008, 1(5): 275-283. doi: 10.1002/aur.42
    [15]
    HEUER L S, ROSE M, ASHWOOD P, et al. Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction[J]. J Neuroimmunol, 2012, 251(1/2): 94-102.
    [16]
    ROBINSON-AGRAMONTE M L A, NORIS GARCÍA E, FRAGA GUERRA J, et al. Immune dysregulation in autism spectrum disorder: what do we know about it[J]. Int J Mol Sci, 2022, 23(6): 3033. doi: 10.3390/ijms23063033
    [17]
    EBRAHIMI MEIMAND S, ROSTAM-ABADI Y, REZAEI N. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment[J]. Expert Rev Clin Immunol, 2021, 17(1): 27-35. doi: 10.1080/1744666X.2020.1850273
    [18]
    WASILEWSKA J, KACZMARSKI M, STASIAK-BARMUTA A, et al. Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old[J]. Arch Med Sci, 2012, 8(2): 324-331.
    [19]
    PETERSON M, PRIGGE M B D, BIGLER E D, et al. Evidence for normal extra-axial cerebrospinal fluid volume in autistic males from middle childhood to adulthood[J]. Neuroimage, 2021, 240: 118387. doi: 10.1016/j.neuroimage.2021.118387
    [20]
    RUNGE K, FIEBICH B L, KUZIOR H, et al. Altered cytokine levels in the cerebrospinal fluid of adult patients with autism spectrum disorder[J]. J Psychiatr Res, 2023, 158: 134-142. doi: 10.1016/j.jpsychires.2022.12.032
    [21]
    PETROZZIELLO T, AMARAL A C, DUJARDIN S, et al. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid[J]. Brain Pathol, 2022, 32(2): e13035. doi: 10.1111/bpa.13035
    [22]
    AHMAD S F, ANSARI M A, NADEEM A, et al. Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children[J]. Mol Immunol, 2019, 106: 77-86.
    [23]
    ROSSIGNOL D A, FRYE R E. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures[J]. Mol Psychiatry, 2012, 17(4): 389-401.
    [24]
    ROSSIGNOL D A, FRYE R E. A systematic review and meta-analysis of immunoglobulin G abnormalities and the therapeutic use of intravenous immunoglobulins (IVIG) in autism spectrum disorder[J]. J Pers Med, 2021, 11(6): 488.
    [25]
    MELAMED I R, HEFFRON M, TESTORI A, et al. A pilot study of high-dose intravenous immunoglobulin 5% for autism: impact on autism spectrum and markers of neuroinflammation[J]. Autism Res, 2018, 11(3): 421-433.
    [26]
    SHARMA A, GOKULCHANDRAN N, SANE H, et al. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study[J]. Stem Cells Int, 2013, 2013: 623875.
    [27]
    LV Y T, ZHANG Y, LIU M, et al. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism[J]. J Transl Med, 2013, 11: 196.
    [28]
    DAWSON G, SUN J M, DAVLANTIS K S, et al. Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder: results of a single-center phase Ⅰ open-label trial[J]. Stem Cells Transl Med, 2017, 6(5): 1332-1339.
  • Related Articles

    [1]ZHANG Shuyuan, HUANG Yongtao, YU Wenjin. Relationship between non-high-density lipoprotein cholesterol and cardiovascular disease in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 106-111. DOI: 10.7619/jcmp.20244504
    [2]MAO Juncong, HONG Yunfei, WEI Yin, CAI Yerui, YIN Jinsong. Application values of triglyceride and glucose index, metabolic insulin resistance score and triglyceride to high-density lipoprotein cholesterol ratio in patients with acute coronary syndrome complicated with multivessel coronary artery disease[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 56-63. DOI: 10.7619/jcmp.20243599
    [3]QIU Xueting, WANG Min, WANG Zhixiao, YANG Tao, SUN Min. Relationship between high density lipoprotein cholesterol level and thyroid autoimmunity[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 1-4, 14. DOI: 10.7619/jcmp.20211491
    [4]YANG Huiqing, HE Chao, SHEN Miaoli, WANG Fei, KONG Yong. Effect of group therapy in treatment of mental disorders patients with metabolic syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 47-50. DOI: 10.7619/jcmp.20201599
    [5]CHEN Yuchi, LIU Qiang. Correlation between monocyte to high-density lipoprotein cholesterol ratio and carotid artery stenosis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 36-39. DOI: 10.7619/jcmp.20201217
    [6]XIN Suping, YE Xinhua. Study on cholesterol in middle-aged and elderly patients with type 2 diabetes mellitus complicated with carotid atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 87-90. DOI: 10.7619/jcmp.202002025
    [7]CHEN Jianbing, CHEN Yinuo, ZHUANG Xiao, FENG Panpan, YANG Fan, WANG Xiang, JI Yue′e, WANG Jinchun. Role of scutellaria baicalensis stem-leaf total flavonoid in regulating blood lipid level of rats with hypertriglyceridemia[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 70-73. DOI: 10.7619/jcmp.201921021
    [8]GUO Ying, PEI Dongmei, ZHANG Naisi. Investigation on infection status of population with Helicobacter pylori infection in Shengyang region[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 99-101, 105. DOI: 10.7619/jcmp.201913028
    [9]XIAO Yuanyuan, HOU Mengling, HE Shenghu. Preliminary study on the changes of residual lipoprotein-cholesterol after three meals in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 6-11. DOI: 10.7619/jcmp.201907003
    [10]ZHANG Guanzhuang. Correlations between cerebral hemorrhage transformation and total cholesterol, low density lipoprotein and high density lipoprotein[J]. Journal of Clinical Medicine in Practice, 2016, (11): 18-20. DOI: 10.7619/jcmp.201611006
  • Cited by

    Periodical cited type(9)

    1. 马雪萍,王晓丽,阿里木江·司马义,徐桂萍. 腹股沟上髂筋膜阻滞复合全身麻醉对高龄髋关节置换患者术后谵妄发生的影响. 新疆医学. 2022(02): 131-134 .
    2. 张宏,李淑萍. 老年患者髋关节置换术后谵妄的发生现状及其相关影响因素分析. 长春中医药大学学报. 2022(10): 1155-1159 .
    3. 刘贵政,郑婷婷,杜斌. 老年髋部骨折患者术后谵妄发生现况及危险因素研究. 贵州医药. 2022(09): 1405-1406 .
    4. 王秀环,鲍乐乐,马漪洁,陈宁宁. 不同麻醉方法对老年髋关节置换患者术后谵妄发生的影响. 广州医科大学学报. 2021(02): 40-44 .
    5. 刘丹,杨万翔. 人文关怀护理对人工髋关节置换术后谵妄患者临床症状的影响. 中国当代医药. 2021(25): 270-272+276 .
    6. 陈立红,徐芙蓉,叶洁玉,许华亮. 高龄骨科髋关节置换术后患者发生谵妄的危险因素分析. 现代医学与健康研究电子杂志. 2021(23): 115-118 .
    7. 毛俊岚. 高龄患者髋关节置换术后谵妄1例的护理. 基层医学论坛. 2020(03): 420-421 .
    8. 欧玉琼,吴建颖,周嫦娥. 以临床路径为指导的谵妄管理对老年股骨头置换术后患者的影响. 护理实践与研究. 2020(02): 86-88 .
    9. 姜红卫. 骨科老年患者髋关节术后谵妄发生原因及疼痛干预护理进展. 系统医学. 2020(13): 196-198 .

    Other cited types(1)

Catalog

    Article views (113) PDF downloads (3) Cited by(10)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return